RE:RE:Email Response from Gilles Gagnon on March 12, 2024Stinzo wrote: I dont know Oats, seems very arrogant to me especially with no track record and no positive momentum for years, 10+ years that is.
we are unfortunately stuck until something gives I guess.
Gilles actually knows the cards the company is holding better than anyone. If he's convinces that can be a great sign. We've never seen the data for the pill or the discussions with potential partners for PGX. With a potential proof of principle through safety/tolerability and preliminary efficacy in 2025 from the Phase I/IIa clinical trial and PGX scale-up to the decision point for mass industrialization of PGX only time will tell if Gilles is right. It's just the nature of the situation that the cards are kept close to the vest at this time. Timelines are long. That's life. The recent director suggests promise and the new President and CEO will add more clarity before key events. How credible will the new person be at this key time for the company.